STABLE PHARMACEUTICAL COMPOSITIONS COMPRISING LIRAGLUTIDE AND DEGLUDEC

Pharmaceutical composition for parenteral administration comprising a basal insulin peptide and an insulinotropic GLP-1 peptide comprising at least 6 zinc atoms per 6 insulin molecules.

Saved in:
Bibliographic Details
Main Authors CHRISTIAN POULSEN, MORTEN SCHLEIN, DORTE BJERRE STEENSGAARD, ANNE PLUM, ANNE SOFIE KJÆR MARCUSSEN, JENS KAALBY THOMSEN
Format Patent
LanguageEnglish
Portuguese
Published 08.02.2017
Subjects
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online AccessGet full text

Cover

More Information
Summary:Pharmaceutical composition for parenteral administration comprising a basal insulin peptide and an insulinotropic GLP-1 peptide comprising at least 6 zinc atoms per 6 insulin molecules.
Bibliography:Application Number: PT20130155712T